Interface Biologics has signed a definitive licence and supply agreement with Navilyst Medical, a leading manufacturer of image-guided medical technologies.

The agreement gives Navilyst exclusive access to Interface Biologics’ Endexo technology.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Endexo is a self-locating bio-medical polymer additive that reduces platelet adhesion, protein adsorption and thrombus formation.

Navilyst Medical chairman and CEO Ron Sparks said that Endexo technology enhances the biocompatibility of the company’s vascular access products.

Navilyst Medical has introduced BioFloPICCs with Endexo Technology, following Canadian approval in August.

Interface Biologics is a developer of transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact